Delivery Order SPE2DB24D8002-SPE2DB25FJNEJ
Award Date
2/20/25
Potential Completion Date
2/21/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DX15D8001|SPE2DX24FBQLK, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,343.17 firm fixed-price delivery order is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product, with a completion date of February 16, 2024. Dakota Drug, Inc. is an established federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,117.14, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract is for the delivery of ANORO ELLIPTA 62.5-25 MCG inhalers, which are used to treat respiratory conditions such as asthma and COPD. This award is structured as a firm fixed-price delivery order and does not have a set-aside designation. Dakota Drug, Inc. is a key...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7E0S, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,936.74 firm fixed-price delivery order is for the procurement of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The contract has an ultimate completion date of June 5, 2024 and was awarded on June 4, 2024. It is not set aside for any specific business...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The contract, valued at $8,358.56, is a firm fixed-price delivery order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The award has an ultimate completion date of February 11, 2025. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical and medical products to support U.S. Armed...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,628.80, is for the delivery of Trelegy Ellipta 200-62.5-25 60s inhalers. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2023. The award is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQXN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,834.67 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through May 13, 2024. Dakota Drug, Inc. is a critical vendor for the DLA's medical supply chain, holding a substantial...
This federal contract award, valued at $14,127.00, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a delivery order for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60S, with a firm fixed-price pricing type and a completion date of September 18, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2WP5, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $7,462.92 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. This contract is not designated as a set-aside. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $2,480.31 Firm Fixed Price Delivery Order contract is for the provision of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of November 30, 2023 and is not designated as a set-aside award. Dakota Drug, Inc. is the prime contractor and has no listed...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,539.65, is a firm fixed-price delivery order with no set-aside designation. The contract provides for the delivery of pharmaceutical products, including treatments for conditions such as diabetes, asthma, COPD, hypertension, and autoimmune disorders. Specific...